Accelera Srl

Accelera Srl

Viale Pasteur 10
Nerviano, Milan, Italy
Phone: +39 0331 1984.444
About the Company

Accelera, a drug development partner, offering a unique background, built on years as part of global R&D organisations (Pharmacia and Pfizer). We provide services and advice to select the best drug candidates and develop new chemical entities and bio-pharmaceuticals into innovative therapies, running optimised IND enabling studies and managing safety, metabolism, pharmacokinetics and bioanalysis issues through clinical proof of concept up to final registration.
With over 25 integrated development programs executed in the last years, we are proud to be working with over 60 sponsors from Europe, North America and Asia.

Services:
• Toxicology and ADME/PK studies in rodent and non-rodent species, including Nonhuman Primates (NHP)
• IND/CTA enabling packages, including GLP general toxicology, safety pharmacology, genotoxicity, ADME and pharmacokinetics (PK)
• Bioanalysis and pharmacokinetics for preclinical and clinical studies, including assay development and validation
• High-throughput preclinical profiling and PB/PK modelling
• PK/PD, and population PK data analysis
• Drug disposition packages, including the synthesis of radiolabeled compound and QWBA
• Full reprotox package
• Preclinical development consultancy and preparation of regulatory documentation
• Special expertise in the design and execution of preclinical development programs for different classes of Oncology drugs.

With Accelera, experience results